Home › Funds › Seven Fleet Capital Management LP › ENTX

Seven Fleet Capital Management LP position in ENTX

ENTERA BIO LTD · Health Care

Seven Fleet Capital Management LP reported holding 6,862,744 shares of ENTX (ENTERA BIO LTD) in its Q3 2026 13F filing — a position valued at US$20.0M, representing 3.90% of its reported portfolio and ranking #5 among its reported holdings. Seven Fleet Capital Management LP has disclosed ENTX holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

Latest position (Q3 2026)6.86M sh
Reported value held$19.97M
Portfolio Weight3.90%
First reportedQ4 2025
Last changeAdd
Updated2026-11-17

Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR

How Seven Fleet Capital Management LP's ENTX position evolved

Seven Fleet Capital Management LP first disclosed a stake in ENTX in Q4 2025 at 135,318 shares (US$263K). The position peaked in Q3 2026 at 6,862,744 shares, worth US$20.0M. Across 4 filings, Seven Fleet Capital Management LP increased the stake 2 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 6,862,744 shares valued at US$20.0M — an increase of 6,671,390 shares quarter over quarter.. Notable position changes include a 52% increase in Q1 2026 (shares rose 59% over the following quarter), a 3486% increase in Q3 2026 (shares rose 4% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2025 135.32K $262.52K New
Q1 2026 205.54K $228.15K Add
Q2 2026 191.35K $338.70K Reduce
Q3 2026 6.86M $19.97M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ENTX and 13F data

ENTX (ENTERA BIO LTD) is a Health Care company. 49 other funds we track also report a position in ENTX — the largest reported positions include BVF INC/IL (US$49.6M), Vivo Capital, LLC (US$35.7M), TCG Crossover Management, LLC (US$35.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ENTX

All ENTX fund holders →

FAQ

How long has Seven Fleet Capital Management LP held ENTX?

Seven Fleet Capital Management LP has disclosed ENTX holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

What is Seven Fleet Capital Management LP's current position in ENTX?

As of Q3 2026, Seven Fleet Capital Management LP holds 6.86M shares of ENTX (ENTERA BIO LTD), valued at $19.97M, representing 3.90% of its reported portfolio and ranking #5.

Has Seven Fleet Capital Management LP been buying or selling ENTX?

In the latest 13F filing (Q3 2026), Seven Fleet Capital Management LP increased its position in ENTX. The position peaked in Q3 2026 at 6.86M shares.

Which other funds hold ENTX?

Other major institutional holders of ENTX include BVF INC/IL, Vivo Capital, LLC, TCG Crossover Management, LLC, among 49 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.